HBV rewires liver cancer signaling by altering PP2A complexes
A. Pitea, R. Turnham, M. Eckhardt, G. M. Jang, Z. Xu, H. C. Lim, A. Choi, J. Von Dollen, R. S. Levin, J. T. Webber, E. McCarthy, J. Hu, X. Li, L. Che, G. Chan, , J. Gordan
This study identifies how HBV alters PP2A complexes to drive liver cancer signaling, revealing potential therapeutic targets.
bioRxiv · Mar 15, 2023 · PreprintCancer Biology